GIACOPPO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 933
EU - Europa 344
AS - Asia 209
AF - Africa 17
Totale 1.503
Nazione #
US - Stati Uniti d'America 915
IT - Italia 193
SG - Singapore 125
CN - Cina 77
UA - Ucraina 57
IE - Irlanda 44
RU - Federazione Russa 20
CA - Canada 18
CI - Costa d'Avorio 16
FI - Finlandia 8
AT - Austria 5
VN - Vietnam 4
DE - Germania 3
NL - Olanda 3
SE - Svezia 3
BE - Belgio 2
BY - Bielorussia 2
PH - Filippine 2
FR - Francia 1
GB - Regno Unito 1
GR - Grecia 1
MK - Macedonia 1
SN - Senegal 1
UZ - Uzbekistan 1
Totale 1.503
Città #
Santa Clara 427
Civitanova Marche 120
Chicago 94
Singapore 92
Boardman 72
Jacksonville 64
Dublin 44
Chandler 32
Nanjing 21
Milan 19
Abidjan 16
Ashburn 16
Andover 13
Catania 13
Cambridge 12
Lawrence 12
Toronto 12
Palermo 11
San Mateo 8
Los Angeles 7
Wilmington 7
Moscow 6
Ottawa 6
Des Moines 5
Hebei 5
Shenyang 5
Bernareggio 4
Dong Ket 4
Helsinki 4
Jiaxing 4
Lappeenranta 4
Nanchang 4
Naples 4
Houston 3
Norwalk 3
Phoenix 3
Salzburg 3
Tianjin 3
Washington 3
Bari 2
Brussels 2
Minsk 2
Omsk 2
Quezon City 2
St Petersburg 2
Zugliano 2
Agordo 1
Amsterdam 1
Bremen 1
Calolziocorte 1
Changchun 1
Changsha 1
Clifton 1
Dakar 1
Flumeri 1
Frankfurt Am Main 1
Giugliano in Campania 1
Groningen 1
Guangzhou 1
Ivanovo 1
Jinan 1
Kunming 1
Liberty Lake 1
Ludwigshafen 1
Palagonia 1
Prineville 1
Skopje 1
Taizhou 1
Valenza 1
Venice 1
Volgograd 1
Totale 1.224
Nome #
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 69
Spontaneous coronary artery dissection 64
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 58
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 57
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry) 56
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 54
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 52
Mid-term clinical outcome of Catania coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 48
Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence from a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients 47
Short and mid-term benefits of coronary stent system with nanothin Polyzene-F in acute coronary syndromes: preliminary result 45
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 44
Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention. 44
Mid-term clinical outcome of CATANIA Coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 43
Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery 41
Meta-analysis of Randomized Controlled Trials of Preprocedural Statin Administration for Reducing Contrast Induced Acute Kidney In Patients Undergoing Coronary Catheterization 40
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 39
PCSK9 inhibitors: current status and emerging frontiers in lipid control 24
Five‐year follow‐up of polymer‐free sirolimus‐ and probucol‐eluting stents versus new generation zotarolimus‐eluting stents in patients presenting with st‐elevation myocardial infarction 22
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials. 22
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study). 22
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis. 21
Current developments in dual antiplatelet therapy after stenting 20
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial 20
Risk of stroke, atrial fibrillation, and major bleeding after mitral valve repair: the jury is still out. 20
Association between surgical risk and 30‐day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta‐analysis. 19
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology. 19
Acute kidney injury after endovascular interventions for critical limb ischemia: Is that a whole different animal? 19
Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique. 19
Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications. 18
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis. 18
Transcatheter versus surgical aortic valve replacement in the digital era: Meta‐analysis based on the reconstruction of time‐to‐event individual patient data. 18
Anticoagulation After Transcatheter Aortic Valve Replacement 18
Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease. 18
Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis. 18
Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis 17
Evaluation of a Low-Dose Radiation Protocol During Transcatheter Aortic Valve Implantation 17
Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials 17
Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents 17
Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y12 Inhibitor Thereafter 17
Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves. 17
Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated? 17
The Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 17
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents. 17
Optimal periprocedural antithrombotic therapy in percutaneous coronary intervention: Between a rock and a hard place? 16
Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data 16
Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial. 15
Molecular multimodality imaging: has a long-standing dream come true? 15
Management of myocardial revascularisation failure: an expert consensus document of the EAPCI 15
Management of in-stent restenosis 15
Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention 15
Impact of bystander-initiated cardiopulmonary resuscitation for out-of-hospital cardiac arrest: where would you be happy to have a cardiac arrest? 15
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis. 15
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis. 15
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials 15
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials 15
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents. 15
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry 15
Radial artery access among mainstays of contemporary percutaneous coronary intervention: Is it time to forget how to puncture a femoral artery? 14
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials. 14
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine 13
Koronare Herzerkrankung mit Hauptstammbeteiliung 13
Totale 1.575
Categoria #
all - tutte 6.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 0 11 0 8 2 9 5
2020/202178 0 8 12 1 21 0 12 0 8 0 12 4
2021/202290 12 13 1 0 16 0 13 6 10 0 2 17
2022/2023127 12 1 1 9 20 21 0 18 40 1 0 4
2023/2024246 1 14 4 14 1 10 0 70 12 14 63 43
2024/2025919 16 174 53 137 328 200 11 0 0 0 0 0
Totale 1.575